We did not observe a significant increase in hsCRP levels in thrombocytosis cases with JAK2-V617F mutations compared with cases without mutant JAK2, but this may likely be explained by the smaller clone sizes in our cohort compared with MPN cases.33 This evidence concerns the gene JAK2 and Thrombocytosis.